Get the tools used by (smart)2 investors.
SP500 2.1%DOW 1.6%FTSE 100 1.1%NIKKEI 0.7%OIL 0.9%GOLD 0.0%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Revenue Forecast (FINBOX)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

-
Price
–
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's Revenue Forecast (FINBOX):

  • Inozyme Pharma Inc's latest twelve months diluted eps incl extra items is -1.62
  • Inozyme Pharma Inc's diluted eps incl extra items for fiscal years ending December 2020 to 2024 averaged -2.46.
  • Inozyme Pharma Inc's operated at median diluted eps incl extra items of -1.78 from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Inozyme Pharma Inc's diluted eps incl extra items peaked in December 2023 at -1.37.
  • Inozyme Pharma Inc's diluted eps incl extra items hit its 5-year low in December 2020 of -5.11.
  • Inozyme Pharma Inc's diluted eps incl extra items decreased in 2024 (-1.62, +18.3%) and increased in 2020 (-5.11, -69.3%), 2021 (-2.40, -53.0%), 2022 (-1.78, -26.1%), and 2023 (-1.37, -22.7%).

Benchmarks

Hide this widget

No data available

Metric Usage

Hide this widget

No data available

Similar Metrics

Hide this widget

No data available

Search for metric or datapoint

Definition of Revenue Forecast (FINBOX)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget

No data available

All rights reserved. Terms Of Use